Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACCESS: Oral Clarithromycin in Community-acquired Pneumonia
NCT04724044Phase 3Completed
- Sponsor
- Hellenic Institute for the Study of Sepsis
- Start
- Jan 2021
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of clarithromycin in community acquired pneumonia (CAP), sepsis, sponsored by Hellenic Institute for the Study of Sepsis. Started Jan 2021; status: completed.
02
Drugs
clarithromycin
03
Conditions
community acquired pneumonia (CAP)sepsis
Beyond the preview
Go deeper on NCT04724044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04724044.